Efficiency of Shock-wave Therapy in Symptomatic Hip Osteoarthritis
NCT ID: NCT04206722
Last Updated: 2019-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2012-06-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Effects of Focused and Radial Shock-Wave Therapies in Hip Osteoarthritis.
NCT05224674
Effects of Various Types of Ultrasound Therapy in Hip Osteoarthritis
NCT03952221
Efficacy of Radial Shockwave Therapy for Treatment of Pain in Knee Osteoarthritis
NCT02197962
Extracorporeal Focused Shock Wave Therapy for Primary Knee Osteoarthritis
NCT02904785
Continuous Radiofrequency in Hip Osteoarthritis Pain: A Randomized Clinical Trial.
NCT06221709
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment group
Shock Wave therapy on the affected hip, for 10 days, 1 application every 2 days
Shock Wave Therapy
Shock Wave therapy - hip osteoarthritis program
Control group
Ultrasound therapy on the affected hip, for 10 days, 1 application daily
Ultrasound
Ultrasound 0.7W/cm2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Shock Wave Therapy
Shock Wave therapy - hip osteoarthritis program
Ultrasound
Ultrasound 0.7W/cm2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iuliu Hatieganu University of Medicine and Pharmacy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ciubean Alina Deniza
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Irsay Laszlo, MD, PhD
Role: STUDY_DIRECTOR
University of Medicine and Pharmacy Iuliu Hatieganu
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UniversitateaMFHIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.